CN101812439A - 一种透皮结构域及其衍生的具有透皮作用的融合蛋白和其制备方法 - Google Patents
一种透皮结构域及其衍生的具有透皮作用的融合蛋白和其制备方法 Download PDFInfo
- Publication number
- CN101812439A CN101812439A CN200910046601A CN200910046601A CN101812439A CN 101812439 A CN101812439 A CN 101812439A CN 200910046601 A CN200910046601 A CN 200910046601A CN 200910046601 A CN200910046601 A CN 200910046601A CN 101812439 A CN101812439 A CN 101812439A
- Authority
- CN
- China
- Prior art keywords
- sod
- sequence
- transdermal
- fusion rotein
- leu
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 108020001507 fusion proteins Proteins 0.000 title claims abstract description 6
- 238000002360 preparation method Methods 0.000 title claims description 6
- 102000037865 fusion proteins Human genes 0.000 title abstract description 4
- 230000009471 action Effects 0.000 title description 2
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 32
- 102000004169 proteins and genes Human genes 0.000 claims abstract description 18
- 230000004927 fusion Effects 0.000 claims description 44
- 108010012715 Superoxide dismutase Proteins 0.000 claims description 43
- 102000019197 Superoxide Dismutase Human genes 0.000 claims description 42
- 229940032362 superoxide dismutase Drugs 0.000 claims description 42
- 241000894006 Bacteria Species 0.000 claims description 13
- 108010018924 Heme Oxygenase-1 Proteins 0.000 claims description 13
- 235000018102 proteins Nutrition 0.000 claims description 13
- 230000000694 effects Effects 0.000 claims description 12
- 239000007788 liquid Substances 0.000 claims description 11
- 102100028006 Heme oxygenase 1 Human genes 0.000 claims description 10
- 102000004190 Enzymes Human genes 0.000 claims description 9
- 108090000790 Enzymes Proteins 0.000 claims description 9
- 229940088598 enzyme Drugs 0.000 claims description 9
- 239000002773 nucleotide Substances 0.000 claims description 8
- 125000003729 nucleotide group Chemical group 0.000 claims description 8
- 239000000047 product Substances 0.000 claims description 7
- 102000004020 Oxygenases Human genes 0.000 claims description 6
- 108090000417 Oxygenases Proteins 0.000 claims description 6
- 230000000968 intestinal effect Effects 0.000 claims description 6
- 239000000203 mixture Substances 0.000 claims description 6
- 239000006228 supernatant Substances 0.000 claims description 6
- PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 claims description 4
- 108091034117 Oligonucleotide Proteins 0.000 claims description 4
- 238000000137 annealing Methods 0.000 claims description 4
- 238000005520 cutting process Methods 0.000 claims description 4
- 108091008146 restriction endonucleases Proteins 0.000 claims description 4
- 108010064696 N,O-diacetylmuramidase Proteins 0.000 claims description 3
- 238000010276 construction Methods 0.000 claims description 3
- 239000013604 expression vector Substances 0.000 claims description 3
- BPHPUYQFMNQIOC-NXRLNHOXSA-N isopropyl beta-D-thiogalactopyranoside Chemical compound CC(C)S[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O BPHPUYQFMNQIOC-NXRLNHOXSA-N 0.000 claims description 3
- 238000003757 reverse transcription PCR Methods 0.000 claims description 3
- 238000002525 ultrasonication Methods 0.000 claims description 3
- 239000002299 complementary DNA Substances 0.000 claims description 2
- 238000001514 detection method Methods 0.000 claims description 2
- 238000009472 formulation Methods 0.000 claims description 2
- 238000003780 insertion Methods 0.000 claims description 2
- 230000037431 insertion Effects 0.000 claims description 2
- 238000004519 manufacturing process Methods 0.000 claims description 2
- 108020004999 messenger RNA Proteins 0.000 claims description 2
- 229910052759 nickel Inorganic materials 0.000 claims description 2
- 238000000746 purification Methods 0.000 claims description 2
- 125000003275 alpha amino acid group Chemical group 0.000 claims 3
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims 1
- 230000008034 disappearance Effects 0.000 claims 1
- 229920001184 polypeptide Polymers 0.000 abstract description 14
- 102000004196 processed proteins & peptides Human genes 0.000 abstract description 14
- 108090000765 processed proteins & peptides Proteins 0.000 abstract description 14
- 230000000149 penetrating effect Effects 0.000 abstract description 2
- 210000004027 cell Anatomy 0.000 description 32
- 210000003491 skin Anatomy 0.000 description 19
- 230000026683 transduction Effects 0.000 description 12
- 238000010361 transduction Methods 0.000 description 12
- 238000000034 method Methods 0.000 description 10
- 230000004083 survival effect Effects 0.000 description 7
- 102100033299 Glia-derived nexin Human genes 0.000 description 6
- 241000282414 Homo sapiens Species 0.000 description 6
- 101000997803 Homo sapiens Glia-derived nexin Proteins 0.000 description 6
- 239000003795 chemical substances by application Substances 0.000 description 6
- 241000700159 Rattus Species 0.000 description 5
- 239000003814 drug Substances 0.000 description 5
- 239000000243 solution Substances 0.000 description 5
- 150000001413 amino acids Chemical class 0.000 description 4
- 238000006243 chemical reaction Methods 0.000 description 4
- 238000004737 colorimetric analysis Methods 0.000 description 4
- 230000006378 damage Effects 0.000 description 4
- 210000002615 epidermis Anatomy 0.000 description 4
- 238000010166 immunofluorescence Methods 0.000 description 4
- 230000003647 oxidation Effects 0.000 description 4
- 238000007254 oxidation reaction Methods 0.000 description 4
- FIKAKWIAUPDISJ-UHFFFAOYSA-L paraquat dichloride Chemical compound [Cl-].[Cl-].C1=C[N+](C)=CC=C1C1=CC=[N+](C)C=C1 FIKAKWIAUPDISJ-UHFFFAOYSA-L 0.000 description 4
- 150000003254 radicals Chemical class 0.000 description 4
- 210000000434 stratum corneum Anatomy 0.000 description 4
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- XUYPXLNMDZIRQH-LURJTMIESA-N N-acetyl-L-methionine Chemical compound CSCC[C@@H](C(O)=O)NC(C)=O XUYPXLNMDZIRQH-LURJTMIESA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 230000003064 anti-oxidating effect Effects 0.000 description 3
- 102220369446 c.1274G>A Human genes 0.000 description 3
- 239000006143 cell culture medium Substances 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 238000001962 electrophoresis Methods 0.000 description 3
- 210000002919 epithelial cell Anatomy 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 229930182817 methionine Natural products 0.000 description 3
- 102220023258 rs387907548 Human genes 0.000 description 3
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 3
- 239000013077 target material Substances 0.000 description 3
- 239000004475 Arginine Substances 0.000 description 2
- 241000588724 Escherichia coli Species 0.000 description 2
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 2
- 238000012408 PCR amplification Methods 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- 241000700157 Rattus norvegicus Species 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 241000700605 Viruses Species 0.000 description 2
- 230000003321 amplification Effects 0.000 description 2
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 2
- 210000000721 basilar membrane Anatomy 0.000 description 2
- 238000004587 chromatography analysis Methods 0.000 description 2
- 229940088503 dermalzone Drugs 0.000 description 2
- 150000002460 imidazoles Chemical class 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 230000035772 mutation Effects 0.000 description 2
- 238000003199 nucleic acid amplification method Methods 0.000 description 2
- 238000006384 oligomerization reaction Methods 0.000 description 2
- 102220023256 rs387907547 Human genes 0.000 description 2
- 210000004927 skin cell Anatomy 0.000 description 2
- -1 thinner Substances 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 1
- AZKSAVLVSZKNRD-UHFFFAOYSA-M 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide Chemical compound [Br-].S1C(C)=C(C)N=C1[N+]1=NC(C=2C=CC=CC=2)=NN1C1=CC=CC=C1 AZKSAVLVSZKNRD-UHFFFAOYSA-M 0.000 description 1
- QCVGEOXPDFCNHA-UHFFFAOYSA-N 5,5-dimethyl-2,4-dioxo-1,3-oxazolidine-3-carboxamide Chemical compound CC1(C)OC(=O)N(C(N)=O)C1=O QCVGEOXPDFCNHA-UHFFFAOYSA-N 0.000 description 1
- 229920000936 Agarose Polymers 0.000 description 1
- 108090000397 Caspase 3 Proteins 0.000 description 1
- 102000003952 Caspase 3 Human genes 0.000 description 1
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 102000002322 Egg Proteins Human genes 0.000 description 1
- 108010000912 Egg Proteins Proteins 0.000 description 1
- 108010043121 Green Fluorescent Proteins Proteins 0.000 description 1
- 102000004144 Green Fluorescent Proteins Human genes 0.000 description 1
- 102000016761 Haem oxygenases Human genes 0.000 description 1
- 108050006318 Haem oxygenases Proteins 0.000 description 1
- 206010020649 Hyperkeratosis Diseases 0.000 description 1
- 208000001126 Keratosis Diseases 0.000 description 1
- 108010019160 Pancreatin Proteins 0.000 description 1
- CWHJIJJSDGEHNS-MYLFLSLOSA-N Senegenin Chemical compound C1[C@H](O)[C@H](O)[C@@](C)(C(O)=O)[C@@H]2CC[C@@]3(C)C(CC[C@]4(CCC(C[C@H]44)(C)C)C(O)=O)=C4[C@@H](CCl)C[C@@H]3[C@]21C CWHJIJJSDGEHNS-MYLFLSLOSA-N 0.000 description 1
- OUUQCZGPVNCOIJ-UHFFFAOYSA-M Superoxide Chemical compound [O-][O] OUUQCZGPVNCOIJ-UHFFFAOYSA-M 0.000 description 1
- 229920004890 Triton X-100 Polymers 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 108010005774 beta-Galactosidase Proteins 0.000 description 1
- 230000008827 biological function Effects 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 102220369447 c.1352G>A Human genes 0.000 description 1
- 244000309466 calf Species 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 230000010001 cellular homeostasis Effects 0.000 description 1
- 210000004691 chief cell of stomach Anatomy 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 239000013599 cloning vector Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 210000000736 corneocyte Anatomy 0.000 description 1
- 230000001086 cytosolic effect Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000003937 drug carrier Substances 0.000 description 1
- 230000002500 effect on skin Effects 0.000 description 1
- 235000014103 egg white Nutrition 0.000 description 1
- 210000000969 egg white Anatomy 0.000 description 1
- 238000005538 encapsulation Methods 0.000 description 1
- 108010048367 enhanced green fluorescent protein Proteins 0.000 description 1
- 210000004920 epithelial cell of skin Anatomy 0.000 description 1
- 235000011194 food seasoning agent Nutrition 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 239000005090 green fluorescent protein Substances 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 230000008595 infiltration Effects 0.000 description 1
- 238000001764 infiltration Methods 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 239000002502 liposome Substances 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- HWYHZTIRURJOHG-UHFFFAOYSA-N luminol Chemical compound O=C1NNC(=O)C2=C1C(N)=CC=C2 HWYHZTIRURJOHG-UHFFFAOYSA-N 0.000 description 1
- 229920002521 macromolecule Polymers 0.000 description 1
- 239000000155 melt Substances 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 239000011259 mixed solution Substances 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 230000004792 oxidative damage Effects 0.000 description 1
- 229940055695 pancreatin Drugs 0.000 description 1
- 238000004091 panning Methods 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 239000012466 permeate Substances 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- BOLDJAUMGUJJKM-LSDHHAIUSA-N renifolin D Natural products CC(=C)[C@@H]1Cc2c(O)c(O)ccc2[C@H]1CC(=O)c3ccc(O)cc3O BOLDJAUMGUJJKM-LSDHHAIUSA-N 0.000 description 1
- 230000008521 reorganization Effects 0.000 description 1
- PYWVYCXTNDRMGF-UHFFFAOYSA-N rhodamine B Chemical compound [Cl-].C=12C=CC(=[N+](CC)CC)C=C2OC2=CC(N(CC)CC)=CC=C2C=1C1=CC=CC=C1C(O)=O PYWVYCXTNDRMGF-UHFFFAOYSA-N 0.000 description 1
- 102220004457 rs11567847 Human genes 0.000 description 1
- 238000009738 saturating Methods 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 238000012163 sequencing technique Methods 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 238000010583 slow cooling Methods 0.000 description 1
- 101150062190 sod1 gene Proteins 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000009871 tenuigenin Substances 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 239000003981 vehicle Substances 0.000 description 1
- 239000011534 wash buffer Substances 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 239000000080 wetting agent Substances 0.000 description 1
Images
Landscapes
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Enzymes And Modification Thereof (AREA)
- Peptides Or Proteins (AREA)
Abstract
Description
Claims (4)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2009100466015A CN101812439B (zh) | 2009-02-25 | 2009-02-25 | 一种透皮结构域及其衍生的具有透皮作用的融合蛋白和其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2009100466015A CN101812439B (zh) | 2009-02-25 | 2009-02-25 | 一种透皮结构域及其衍生的具有透皮作用的融合蛋白和其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101812439A true CN101812439A (zh) | 2010-08-25 |
CN101812439B CN101812439B (zh) | 2012-07-04 |
Family
ID=42619806
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2009100466015A Active CN101812439B (zh) | 2009-02-25 | 2009-02-25 | 一种透皮结构域及其衍生的具有透皮作用的融合蛋白和其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN101812439B (zh) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103201386A (zh) * | 2010-11-09 | 2013-07-10 | 加利福尼亚大学董事会 | 皮肤穿透及细胞进入(space)肽及其使用方法 |
CN106366161A (zh) * | 2012-05-31 | 2017-02-01 | Lg生活健康株式会社 | 皮肤透过性肽 |
CN114805593A (zh) * | 2021-01-19 | 2022-07-29 | 盛世泰研(广东)健康科技有限公司 | 一种具有穿膜功能的Penetratin-hSOD1及其制备方法与应用 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7264948B2 (en) * | 2002-08-30 | 2007-09-04 | University Of Pittsburgh | Polypeptides for increasing mutant CFTR channel activity |
CN1686081A (zh) * | 2005-04-12 | 2005-10-26 | 福州大学 | Ptd-sod融合蛋白及其衍生物在化妆品中的应用 |
CN100387623C (zh) * | 2005-05-20 | 2008-05-14 | 福州大学 | 连接蛋白转导结构域及辅助蛋白的生物活性蛋白、它的制备方法和应用 |
-
2009
- 2009-02-25 CN CN2009100466015A patent/CN101812439B/zh active Active
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103201386A (zh) * | 2010-11-09 | 2013-07-10 | 加利福尼亚大学董事会 | 皮肤穿透及细胞进入(space)肽及其使用方法 |
US8791062B2 (en) | 2010-11-09 | 2014-07-29 | The Regents Of The University Of California | Skin permeating and cell entering (SPACE) peptides and methods of use thereof |
US9441014B2 (en) | 2010-11-09 | 2016-09-13 | The Regents Of The University Of California | Skin permeating and cell entering (SPACE) peptides and methods of use thereof |
CN106366161A (zh) * | 2012-05-31 | 2017-02-01 | Lg生活健康株式会社 | 皮肤透过性肽 |
CN106366161B (zh) * | 2012-05-31 | 2019-12-06 | Lg生活健康株式会社 | 皮肤透过性肽 |
CN114805593A (zh) * | 2021-01-19 | 2022-07-29 | 盛世泰研(广东)健康科技有限公司 | 一种具有穿膜功能的Penetratin-hSOD1及其制备方法与应用 |
Also Published As
Publication number | Publication date |
---|---|
CN101812439B (zh) | 2012-07-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Pesquero et al. | Molecular cloning and functional characterization of a mouse bradykinin B1 receptor gene | |
Southby et al. | Alternative promoter usage and mRNA splicing pathways for parathyroid hormone-related protein in normal tissues and tumours | |
JPH10327880A (ja) | ヒト・ナトリウム依存性リン酸輸送体(ipt−1) | |
JP2003527067A (ja) | Acrp30(30kdの脂肪細胞補体関連タンパク質)の相同体acrp30r1l | |
WO2006068625A1 (en) | Novel snake toxin | |
Veenstra et al. | Identification of three allatostatins and their cDNA from the mosquito Aedes aegypti | |
Ohira et al. | Molecular cloning and expression analysis of cDNAs encoding androgenic gland hormone precursors from two porcellionidae species, Porcellio scaber and P. dilatatus | |
Liu et al. | Molecular cloning, characterization and recombinant expression of crustacean hyperglycemic hormone in white shrimp Litopenaeus vannamei | |
Edwards et al. | Expression of Na+/H+ exchanger mRNA in the gills of the Atlantic hagfish (Myxine glutinosa) in response to metabolic acidosis | |
Yang et al. | Synthesis and secretion of selenoprotein P by cultured rat astrocytes | |
US6599718B1 (en) | Growth hormone secretagogue related receptors and nucleic acids | |
JPH1198988A (ja) | ヒト7膜貫通受容体をコードするcDNAクローンHEOAD54 | |
CA2327259A1 (en) | Human transcriptional regulator molecules | |
CN101812439B (zh) | 一种透皮结构域及其衍生的具有透皮作用的融合蛋白和其制备方法 | |
Liu et al. | Molecular and functional characterization of a CD59 analogue from large yellow croaker Pseudosciana crocea | |
US20140088024A1 (en) | Vesiculins | |
CN101003788A (zh) | 一种蝎抗肿瘤转移肽及其制备方法和应用 | |
Pongsomboon et al. | Gene expression and activity of carbonic anhydrase in salinity stressed Penaeus monodon | |
De Zoysa et al. | A novel Fas ligand in mollusk abalone: molecular characterization, immune responses and biological activity of the recombinant protein | |
Wang et al. | Structural and expression analysis of hepatic vitellogenin gene during ovarian maturation in Anguilla japonica | |
Shin et al. | Molecular characterization and expression analysis of stanniocalcin-1 in turbot (Scophthalmus maximus) | |
Zheng et al. | Molecular cloning of a putative receptor guanylyl cyclase from Y-organs of the blue crab, Callinectes sapidus | |
Hang et al. | Stanniocalcin in the euryhaline flounder (Platichthys flesus): primary structure, tissue distribution, and response to altered salinity | |
Lao et al. | Molecular cloning of two C1q-like cDNAs in mandarin fish Siniperca chuatsi | |
CN112375132B (zh) | 太湖白鱼来源的抗菌肽及其应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
DD01 | Delivery of document by public notice |
Addressee: Zhang Jingquan Document name: Notification of Passing Examination on Formalities |
|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
DD01 | Delivery of document by public notice |
Addressee: Zhang Shuyu Document name: Notification of Patent Invention Entering into Substantive Examination Stage |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: ANHUI DAZHONG BIOTECHNOLOGY CO., LTD. Free format text: FORMER OWNER: ZHANG SHUYU Effective date: 20120831 |
|
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 200433 YANGPU, SHANGHAI TO: HEFEI, ANHUI PROVINCE |
|
TR01 | Transfer of patent right |
Effective date of registration: 20120831 Address after: Room 606, private science and technology innovation service center, No. 605 Mount Huangshan Road, Hefei hi tech Development Zone Patentee after: Anhui Dazhong biological science and Technology Co Ltd Address before: 200433, room 125, building 57, Lane 201, Wu Dong Road, Shanghai Patentee before: Zhang Shuyu |
|
DD01 | Delivery of document by public notice |
Addressee: Zhang Jingquan Document name: Notification of Passing Examination on Formalities |
|
TR01 | Transfer of patent right |
Effective date of registration: 20191106 Address after: Room 601, private science and technology entrepreneurship service center, No. 605, Huangshan Road, hi tech Zone, Hefei City, Anhui Province Patentee after: Xu Qiusheng Address before: Room 606, private science and technology innovation service center, No. 605 Mount Huangshan Road, Hefei hi tech Development Zone Patentee before: Anhui Dazhong biological science and Technology Co Ltd |
|
TR01 | Transfer of patent right |